You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

340 Results
Guidelines and Advice
Status: In-Review
ID: GL 2-24
May 2019
Document
Document
Document
Drug
Other Name(s): Unituxin®
Jun 2023
Statistical Reports
This page is for drug manufacturers who need information on the cancer drug submission process. Please do not mail cancer drug submissions to Ontario...

Pages